The<unk>  <unk>  is a clinical trial outcome measure of assessing the severity of<unk>  sclerosis primarily used in research. The score is based on a combination of timed tests of walking, arm function, and cognitive ability. It was developed over two years from 1994 to 1996 by the National<unk>  Sclerosis Society.<unk>  was developed to improve the standard measure of MS disability for clinical trials and to create a multidimensional metric of overall MS clinical status. The evaluation includes a three-part performance scale: * Timed 25-Foot Walk (T25FT) - assessment of leg function by moving a short walking distance * 9-Hole Peg Test (9HPT) - assessment of arm function using breadboard test * Paced Auditory Serial Addition test (PASAT) - attention/concentration test to assess cognitive functions An integrated<unk>  score is calculated using z-scores.
Multiple sclerosis functional composite
Amyotrophic lateral sclerosis research
Charcot–Marie–Tooth disease classifications
Patient Reported Outcome Indices for Multiple Sclerosis
Multiple sclerosis biomarkers
Multiple sclerosis research
Alzheimer's disease biomarkers
Genetics of amyotrophic lateral sclerosis